Featured Abstracts
Review key findings and research highlights presented at major industry conferences and events.
Featured Content
ESTRO 2026
Preoperative radiotherapy in a single fraction for early stage breast cancer: the CRYSTAL phase I/II study update (AIRC IG-23118)
ESTRO 2026
Initial clinical experience of RayStation-based online adaptive RT using Radixact for endometrial cancer.
ESTRO 2026
One-year cumulative toxicity in 25 prostate cancer patients treated with single fraction (24 Gy) urethra-sparing radiosurgery (PRO-FAST NCT05936736 )
Featured Case Studies
Robotic Stereotactic Body Radiation Therapy For High-risk Prostate Cancer: The Georgetown University Experience
This retrospective study examines cancer control and health-related quality of life (HRQOL) outcomes in high-risk prostate cancer patients receiving robotic stereotactic body radiation therapy (SBRT) with Synchrony® real-time adaptive motion management.
Use of Motion Management to Model Unmanaged Motion: Dosimetric Consequences of Unmanaged Prostate Motion Assessed Using Real-time Radiotherapy Adaptation Data
This case report explores the dosimetric impact of unmanaged intrafraction prostate motion during radiotherapy by retrospectively analyzing real-time motion data collected using the Radixact® System with Synchrony®. The study models what would have happened if a patient had been treated without motion management, using deformation vector fields to simulate dose
Stereotactic Body Radiotherapy of a Lung Tumor with Large Respiratory Motion Using Real-time Adaptive Motion Management: A Case Report
Traditional internal target volume (ITV) methods for the treatment of a lung tumor on conventional linac would require a large planning target volume (PTV), risking high radiation exposure to the chest wall and lungs.
Evaluation of Necessary and Sufficient PTV Margins for Offline Adaptive Head and Neck Cases Treated with TomoTherapy
Rose Kamal et al. | ASTRO | 2025
What is the Optimal Strategy for Re-Planning of Adaptive Radiotherapy of Head and Neck Cancer?
Hedda Enocson et al. | ASTRO | 2025
The Effect of Radiation Techniques on Carbon Footprint Reduction
Yu-Hsuan Chuang et al. | ASTRO | 2025
FLT-PET-Guided Dose-Escalated TMLI with Integrated Boost for AML: A Dosimetric Feasibility Study
Chunhui Han et al. | ASTRO | 2025
The Changing Dogma in Oligometastatic Renal Cell Carcinoma – SBRT
Papaiah Susheela Sridhar et al. | ASTRO | 2025
Ablative Radiotherapy for Inoperable Non-Metastatic Pancreatic Cancer: Long-Term Results in a Single Center
Jing Wang et al. | ASTRO | 2025
Reirradiation with SBRT in Radiorecurrent Prostate Cancer: Impact on Disease Control and Quality of Life Outcomes
Papaiah Sridhar et al. | ASTRO | 2025
PSMA Based Dose Escalation to Dominant Intraprostatic Lesion (DIL) in Localized Carcinoma Prostate Treated with Stereotactic Body Radiotherapy
Papaiah Susheela Sridhar et al. | ASTRO | 2025
Optimizing PTV Generation and Comparison of OAR Dosimetry with Different Rectal Spacers in Patients Treated with HDR-Like Prostate SBRT
Emily Hollis et al. | ASTRO | 2025
